NCT00798889View on ClinicalTrials.gov

Rollover Protocol for Prior SU011248 Protocols

NACompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Solid Tumors
Interventions
DRUG

Sunitinib

Sunitinib dose varies according to the doses allowed in previous protocol. It is given once a day, orally with various schedules depending on the parent protocol

Trial Locations (59)

2031

Pfizer Investigational Site, Randwick

3002

Pfizer Investigational Site, East Melbourne

3084

Pfizer Investigational Site, Heidelberg

10021

Pfizer Investigational Site, New York

10022

Pfizer Investigational Site, New York

10032

Pfizer Investigational Site, New York

19111

Pfizer Investigational Site, Philadelphia

20133

Pfizer Investigational Site, Milan

20141

Pfizer Investigational Site, Milan

27710

Pfizer Investigational Site, Durham

29572

Pfizer Investigational Site, Myrtle Beach

35233

Pfizer Investigational Site, Birmingham

35294

Pfizer Investigational Site, Birmingham

37066

Pfizer Investigational Site, Gallatin

37067

Pfizer Investigational Site, Franklin

37076

Pfizer Investigational Site, Hermitage

37087

Pfizer Investigational Site, Lebanon

37130

Pfizer Investigational Site, Murfreesboro

37167

Pfizer Investigational Site, Smyrna

37203

Pfizer Investigational Site, Nashville

37205

Pfizer Investigational Site, Nashville

37207

Pfizer Investigational Site, Nashville

37211

Pfizer Investigational Site, Nashville

37212

Pfizer Investigational Site, Nashville

37232

Pfizer Investigational Site, Nashville

44195

Pfizer Investigational Site, Cleveland

46202

Pfizer Investigational Site, Indianapolis

48201

Pfizer Investigational Site, Detroit

48334

Pfizer Investigational Site, Farmington Hills

53792

Pfizer Investigational Site, Madison

63110

Pfizer Investigational Site, St Louis

75246

Pfizer Investigational Site, Dallas

80045

Pfizer Investigational Site, Aurora

87106

Pfizer Investigational Site, Albuqurque

90033

Pfizer Investigational Site, Los Angeles

90095

Pfizer Investigational Site, Los Angeles

90404

Pfizer Investigational Site, Santa Monica

94115

Pfizer Investigational Site, San Francisco

94805

Pfizer Investigational Site, Villejuif

308433

Pfizer Investigational Site, Singapore

35233-2115

Pfizer Investigational Site, Birmingham

94115-1705

Pfizer Investigational Site, San Francisco

02114

Pfizer Investigational Site, Boston

02115

Pfizer Investigational Site, Boston

02215

Pfizer Investigational Site, Boston

48109-0843

Pfizer Investigational Site, Ann Arbor

55455-0392

Pfizer Investigational Site, Minneapolis

87131-0001

Pfizer Investigational Site, Albuquerque

77030-4009

Pfizer Investigational Site, Houston

H2L 4M1

Pfizer Investigational Site, Montreal

564 03

Pfizer Investigational Site, Thessaloniki

6525 GA

Pfizer Investigational Site, Nijmegen

Unknown

Pfizer Investigational Site, Lund

Pfizer Investigational Site, Stockholm

CH-9007

Pfizer Investigational Site, Sankt Gallen

LS9 7TF

Pfizer Investigational Site, Leeds

NW1 2PG

Pfizer Investigational Site, London

SW3 6JJ

Pfizer Investigational Site, London

NE4 6BE

Pfizer Investigational Site, Newcastle upon Tyne

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00798889 - Rollover Protocol for Prior SU011248 Protocols | Biotech Hunter | Biotech Hunter